ENTITY
Acadia Pharmaceuticals

Acadia Pharmaceuticals (ACAD US)

27
Analysis
Health CareUnited States
ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.
more
Company Presentation07 Nov 2024 05:30
Company Presentation23 Aug 2024 20:00
Company Presentation07 Aug 2024 04:30
Company Presentation09 May 2024 04:30
Company Presentation09 Aug 2018 05:00
x